David H Mason Selected Research

CTP37 peptide

7/2002

Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David H Mason Research Topics

Disease

1	Prostatic Neoplasms (Prostate Cancer) 07/2003
1	Neoplasms (Cancer) 07/2003
1	Colorectal Neoplasms (Colorectal Cancer) 07/2002

Drug/Important Bio-Agent (IBA)

1	AVI-4126IBA 07/2003
1	AndrogensIBA 07/2003
1	MorpholinosIBA 07/2003
1	CTP37 peptideIBA 07/2002
1	Peptides (Polypeptides)IBA 07/2002
1	Synthetic Vaccines (Recombinant Vaccines)IBA 07/2002
1	Protein Subunit VaccinesIBA 07/2002
1	AntibodiesIBA 07/2002
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 07/2002
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 07/2002

Therapy/Procedure

1	Immunotherapy 07/2002